Form 8-K - Current report:
SEC Accession No. 0000950170-25-002291
Filing Date
2025-01-06
Accepted
2025-01-06 17:09:57
Documents
11
Period of Report
2025-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20250102.htm   iXBRL 8-K 36951
  Complete submission text file 0000950170-25-002291.txt   146171

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20250102.xsd EX-101.SCH 23908
13 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20250102_htm.xml XML 4516
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 25512261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)